179 related articles for article (PubMed ID: 31043777)
1. EGFP-EGF1-conjugated poly(lactic-co-glycolic acid) nanoparticles, a new diagnostic tool and drug carrier for atherosclerosis.
Wu Z; Chen C; Zhang B; Tang L; Shi W; Liao D; Di G; Davis JR; Wang H
Int J Nanomedicine; 2019; 14():2609-2618. PubMed ID: 31043777
[TBL] [Abstract][Full Text] [Related]
2. EGFP-EGF1-conjugated poly (lactic-co-glycolic acid) nanoparticles as a carrier for the delivery of CCR2- shRNA to atherosclerotic macrophage in vitro.
Wu Z; Chen C; Luo J; Davis JRJ; Zhang B; Tang L; Shi W; Liao D
Sci Rep; 2020 Nov; 10(1):19636. PubMed ID: 33184330
[TBL] [Abstract][Full Text] [Related]
3. A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapy.
Shi W; Yin Y; Wang Y; Zhang B; Tan P; Jiang T; Mei H; Deng J; Wang H; Guo T; Pang Z; Hu Y
Oncotarget; 2017 May; 8(19):32212-32227. PubMed ID: 27793028
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Antitumor Activity of EGFP-EGF1-Conjugated Nanoparticles by a Multitargeting Strategy.
Zhang B; Jiang T; Ling L; Cao Z; Zhao J; Tuo Y; She X; Shen S; Jiang X; Hu Y; Pang Z
ACS Appl Mater Interfaces; 2016 Apr; 8(14):8918-27. PubMed ID: 26890991
[TBL] [Abstract][Full Text] [Related]
5. Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy.
Chu Q; Xu H; Gao M; Guan X; Liu H; Deng S; Huo X; Liu K; Tian Y; Ma X
Int J Nanomedicine; 2016; 11():449-63. PubMed ID: 26869788
[TBL] [Abstract][Full Text] [Related]
6. EGFP-EGF1-conjugated PLGA nanoparticles for targeted delivery of siRNA into injured brain microvascular endothelial cells for efficient RNA interference.
Chen C; Mei H; Shi W; Deng J; Zhang B; Guo T; Wang H; Hu Y
PLoS One; 2013; 8(4):e60860. PubMed ID: 23593330
[TBL] [Abstract][Full Text] [Related]
7. A tissue factor targeted nanomedical system for thrombi-specific drug delivery.
Shi W; Mei H; Deng J; Chen C; Wang H; Guo T; Zhang B; Li L; Pang Z; Jiang X; Shen S; Hu Y
Biomaterials; 2012 Oct; 33(30):7643-54. PubMed ID: 22819496
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles.
Panyam J; Sahoo SK; Prabha S; Bargar T; Labhasetwar V
Int J Pharm; 2003 Aug; 262(1-2):1-11. PubMed ID: 12927382
[TBL] [Abstract][Full Text] [Related]
9. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit
Naeem M; Bae J; Oshi MA; Kim MS; Moon HR; Lee BL; Im E; Jung Y; Yoo JW
Int J Nanomedicine; 2018; 13():1225-1240. PubMed ID: 29535519
[TBL] [Abstract][Full Text] [Related]
10. EGFP-EGF1 protein-conjugated PEG-PLA nanoparticles for tissue factor targeted drug delivery.
Mei H; Shi W; Pang Z; Wang H; Lu W; Jiang X; Deng J; Guo T; Hu Y
Biomaterials; 2010 Jul; 31(21):5619-26. PubMed ID: 20413154
[TBL] [Abstract][Full Text] [Related]
11. Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy.
Zhang M; He J; Jiang C; Zhang W; Yang Y; Wang Z; Liu J
Int J Nanomedicine; 2017; 12():533-558. PubMed ID: 28144137
[TBL] [Abstract][Full Text] [Related]
12. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
Mao J; Meng X; Zhao C; Yang Y; Liu G
Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310
[TBL] [Abstract][Full Text] [Related]
13. Phagocytosis of polymeric nanoparticles aided activation of macrophages to increase atherosclerotic plaques in ApoE
Yin T; Li Y; Ren Y; Fuad ARM; Hu F; Du R; Wang Y; Wang G; Wang Y
J Nanobiotechnology; 2021 Apr; 19(1):121. PubMed ID: 33910571
[TBL] [Abstract][Full Text] [Related]
14. EGFP-EGF1-conjugated nanoparticles for targeting both neovascular and glioma cells in therapy of brain glioma.
Zhang B; Wang H; Liao Z; Wang Y; Hu Y; Yang J; Shen S; Chen J; Mei H; Shi W; Hu Y; Pang Z; Jiang X
Biomaterials; 2014 Apr; 35(13):4133-45. PubMed ID: 24529623
[TBL] [Abstract][Full Text] [Related]
15. Elimination of mouse tumor cells from neonate spermatogonial cells utilizing cisplatin-entrapped folic acid-conjugated poly(lactic-co-glycolic acid) nanoparticles in vitro.
Shabani R; Ashjari M; Ashtari K; Izadyar F; Behnam B; Khoei S; Asghari-Jafarabadi M; Koruji M
Int J Nanomedicine; 2018; 13():2943-2954. PubMed ID: 29849458
[TBL] [Abstract][Full Text] [Related]
16. Comparative receptor based brain delivery of tramadol-loaded poly(lactic-co-glycolic acid) nanoparticles.
Lalani J; Raichandani Y; Mathur R; Lalan M; Chutani K; Mishra AK; Misra A
J Biomed Nanotechnol; 2012 Dec; 8(6):918-27. PubMed ID: 23030000
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
18. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
Srivastava S; Gupta S; Mohammad S; Ahmad I
J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
[TBL] [Abstract][Full Text] [Related]
19. Cellular delivery of PEGylated PLGA nanoparticles.
Pamujula S; Hazari S; Bolden G; Graves RA; Chinta DD; Dash S; Kishore V; Mandal TK
J Pharm Pharmacol; 2012 Jan; 64(1):61-7. PubMed ID: 22150673
[TBL] [Abstract][Full Text] [Related]
20. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
